Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from iSpecimen ( (ISPC) ).
On December 31, 2025, iSpecimen Inc. convened its 2025 Annual Meeting of Stockholders but adjourned it after failing to reach a quorum, preventing votes on the proposals outlined in its November 21, 2025 proxy materials. The meeting was reconvened on January 23, 2026, and again on February 13, 2026, but both sessions were again adjourned for lack of quorum, underscoring apparent stockholder participation challenges.
The company now plans to reconvene the Annual Meeting on March 13, 2026, at 9:00 a.m. Eastern Time, maintaining November 3, 2025, as the record date for eligible voters. No changes have been made to the proposals up for vote, indicating iSpecimen is focused on securing sufficient stockholder turnout to complete standard governance business rather than altering its planned agenda, a situation that may delay corporate decisions dependent on shareholder approval.
The most recent analyst rating on (ISPC) stock is a Sell with a $0.34 price target. To see the full list of analyst forecasts on iSpecimen stock, see the ISPC Stock Forecast page.
Spark’s Take on ISPC Stock
According to Spark, TipRanks’ AI Analyst, ISPC is a Neutral.
The score is weighed down primarily by weak financial performance (sharp TTM revenue decline, margin deterioration, ongoing losses, and persistent cash burn). Technicals add a mixed-to-weak backdrop (below key longer-term moving averages with negative MACD). Corporate events and valuation provide limited offset given Nasdaq bid-price compliance risk and a negative P/E tied to ongoing losses.
To see Spark’s full report on ISPC stock, click here.
More about iSpecimen
iSpecimen Inc. operates in the life sciences and healthcare research industry, focusing on connecting researchers with human biospecimens collected from a network of providers. The company’s platform supports scientific and medical studies by streamlining access to specimens needed for diagnostics, drug development, and other research applications.
Average Trading Volume: 1,645,210
Technical Sentiment Signal: Strong Sell
Current Market Cap: $2.96M
Find detailed analytics on ISPC stock on TipRanks’ Stock Analysis page.